Valuation: Bayer AG

Market Cap 45.22B 50.4B 41.81B 37.86B 70.74B 4,800B 71.6B 500B 199B 2,512B 189B 185B 7,974B P/E 2026 *
19.5x
P/E 2027 * 14.6x
Enterprise Value 74.89B 83.47B 69.24B 62.71B 117B 7,950B 119B 828B 330B 4,160B 313B 307B 13,207B EV / Sales 2026 *
1.63x
EV / Sales 2027 * 1.52x
Free-Float
99.99%
Yield 2026 *
0.3%
Yield 2027 * 1.21%
1 day+1.76%
1 week+5.63%
Current month-2.61%
1 month-4.46%
3 months-2.08%
6 months+28.12%
Current year+26.18%
1 week 43.31
Extreme 43.31
46.7
1 month 42.56
Extreme 42.56
49.68
Current year 32.96
Extreme 32.96
53.92
1 year 25.78
Extreme 25.78
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 61 2017-03-31
Chairman 68 2020-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 Buy

Director

1,900 0.0002%
3/18/26 Buy

Executive/Senior Manager

13,000 0.0013%
3/18/26 Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.75%+5.63%+69.45%+14.80% 50.4B
+0.50%+1.38%+57.09%+129.96% 1,148B
+0.86%+5.14%+45.00%+86.15% 652B
-0.14%+0.42%+25.69%+105.85% 505B
+0.59%+2.32%+54.07%+66.27% 384B
-0.63%-5.97%+61.93%+37.06% 348B
+3.20%+3.32%+35.19%+57.34% 294B
+1.79%-0.25%+3.09%+26.72% 264B
+0.87%+3.08%+54.69%+72.74% 244B
+0.08%+3.67%+35.05%+107.78% 197B
Average +1.80%+1.56%+44.12%+70.47% 408.76B
Weighted average by Cap. +2.11%+1.52%+45.29%+88.31%

Financials

2026 *2027 *
Net sales 45.87B 51.12B 42.41B 38.41B 71.76B 4,869B 72.62B 507B 202B 2,548B 192B 188B 8,089B 47.05B 52.44B 43.5B 39.4B 73.6B 4,995B 74.49B 520B 207B 2,614B 197B 193B 8,297B
Net income 2.3B 2.56B 2.12B 1.92B 3.59B 244B 3.64B 25.39B 10.11B 128B 9.61B 9.4B 405B 3.02B 3.37B 2.8B 2.53B 4.73B 321B 4.79B 33.43B 13.32B 168B 12.65B 12.38B 533B
Net Debt 29.67B 33.07B 27.43B 24.85B 46.42B 3,150B 46.98B 328B 131B 1,648B 124B 121B 5,233B 26.44B 29.46B 24.44B 22.13B 41.35B 2,806B 41.85B 292B 116B 1,468B 111B 108B 4,662B
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
26-10-29 €46.70 +1.46% 331,395
26-10-28 €46.03 -0.26% 1,786,980
26-10-27 €46.15 +1.29% 1,801,210
26-10-26 €45.56 +3.59% 1,964,992
26-10-23 €43.98 -0.52% 1,183,777
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
46.03EUR
Average target price
58.33EUR
Spread / Average Target
+26.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bayer AG
  1. Stock Market
  2. Stocks
  3. BAYN Stock